Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026)
Turn Therapeutics' (TTRX) quarterly Cash from Investing Activities came in at -$12227.0 in Q1 2026, up 61.11% quarter-over-quarter from -$31441.0 in Q4 2025.
Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Turn Therapeutics' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$12227.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 172.62 Mn |
| 10 | Turn Therapeutics | 253.20 Mn | 253.20 Mn | - | -12,227.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,227.00 |
| Mar 31, 2026 | -12,227.00 |
| Dec 31, 2025 | -31,441.00 |
| Dec 31, 2025 | -31,441.00 |
| Dec 31, 2024 | -7,842.00 |
| Dec 31, 2024 | -7,842.00 |